Answer
Stelara (ustekinumab) 130 mg concentrate for solution for infusion should not be administered simultaneously with other medicines through the same intravenous line, must not be mixed with other medicinal products in the absence of compatibility studies, and should only be diluted with sodium chloride 9 mg/mL (0.9%) solution.
Sources for this answer
- STELARA 130 mg concentrate for solution for infusionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §6.2 Incompatibilities · Version 25Document updated
Sources checked